Allscripts-Misys (MDRX) Commences 25M Common Offering
Down)
Allscripts-Misys Healthcare Solutions, Inc. (Nasdaq: MDRX) today announced that it has commenced an underwritten public offering of 25,000,000 shares of its common stock on behalf of certain wholly-owned subsidiaries of Misys plc, Allscripts' majority stockholder. The shares are being sold by Misys to reduce its equity stake in Allscripts pursuant to the Framework Agreement between Misys and Allscripts, as previously announced in connection with Allscripts' pending merger with Eclipsys Corporation (Nasdaq: ECLP). The offering includes an option for the underwriters to purchase up to 3,750,000 additional shares from the selling stockholders to cover over-allotments, if any.
Allscripts will not sell any shares in the offering and will not receive any proceeds from the offering.
Credit Suisse, Barclays Capital, J.P. Morgan and UBS Investment Bank will act as joint book-running managers of the offering.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Allscripts will not sell any shares in the offering and will not receive any proceeds from the offering.
Credit Suisse, Barclays Capital, J.P. Morgan and UBS Investment Bank will act as joint book-running managers of the offering.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- HealthCor Obtains Expedited Review by Delaware Court of Chancery for Lawsuit Against Allscripts
- New York Mortgage Trust (NYMT) Prices 2.75M Offering at $6.65/Share
- Lazard Starts ATHN, CERN, QSII, MDAS at Buy, MDRX, OMCL, CPSI, EHTH at Neutral, EPOC at Sell
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Credit Suisse, UBS, JPMorgan, BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
